expired vaccine used; This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 010M20A) for COVID-19 vaccination.     The patient's past medical history included Hypercalcemia, Heart attack (FH HEART ATTACK), Sinus bradycardia and Back pain. Previously administered products included for Drug use for unknown indication: influenza (influenza series1) on 23-Sep-2019, influenza (influenza series 1) on 14-Sep-2020 and influenza (influenza series 2) on 25-Oct-2021. Past adverse reactions to the above products included No adverse event with influenza, influenza and influenza. Concurrent medical conditions included Adenocarcinoma of the prostate stage II (Adanocarcinoma, prostate, Gleason Grade 7), Carpal tunnel syndrome (Carpal tunnel syndrome of right wrist), Inguinal pain (Inguinal pain, right), Hip discomfort (Hip pain. right), Hearing loss, Flank pain (Low back flank pain, !eft), Subconjunctival hemorrhage (Subconjunctival hemorrhage, right), GERD, Memory loss, Transient global amnesia, Lateral epicondylitis, Melanoma (Melanoma left arm), Type II diabetes mellitus (DIABETES MELLITUS, TYPE It, CONTROLLED, MILD), Esophageal stricture, Reflux esophagitis, Nevus (NEVUS. ATYPICAL), Colon adenoma (TUBULOVILLOUS ADENOMA, COLON), Gout, Hyperlipidemia and Hypertension. Concomitant products included LANSOPRAZOLE (PREVACID) for Esophageal reflux, INDOMETHACIN [INDOMETACIN] for Gouty pain, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ), ACETYLSALICYLIC ACID (ASPIRIN 81), OMEGA-3 FATTY ACIDS, CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]), AMLODIPINE BESILATE, ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM GENERIC), METFORMIN HCL, TART CHERRY and SILDENAFIL CITRATE (VIAGRA) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 10-Nov-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose increased: elevated (High) elevated. On an unknown date, Blood iron increased: elevated (High) Iron, serum, elevated. On an unknown date, Investigation: results not provided (Inconclusive) results not provided, results not provided (Inconclusive) results not provided, results not provided (Inconclusive) results not provided and results not provided (Inconclusive) results not provided. On an unknown date, Prostatic specific antigen: 4.5 (High) elevated at 4.5.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Observation and evaluation for suspected exposure to other biological agent Exercise, Screening for  Lung cancer,Skin Cancer,colon cancer, prostate cancer routine  physical exam.Patient has no known allergies. No Treatment information was provided.